News

CLEOPATRA sets new standard treatment paradigm for metastatic breast cancer

Posted on: 08/10/2014 - 14:15

MADRID – First-line dual targeted therapy with pertuzumab and trastuzumab plus chemotherapy gives women with HER2-positive metastatic breast cancer an additional 15.7 months of life, according to the...

Field of Interest: Oncology

Type: News Item

CLEOPATRA sets new standard treatment paradigm for metastatic breast cancer

Posted on: 08/10/2014 - 14:15

Field of Interest: Pulmonology

Type: News Item

Duodenoscopes transmitted resistant E. coli to 39 patients

Posted on: 07/10/2014 - 21:18

Contaminated duodenoscopes triggered a 2013 outbreak of a rare strain of Escherichia coli infections at a single hospital in northeastern Illinois, according to a report published online Oct....

Field of Interest: Gastroentero...

Type: News Item

Rolapitant curbs chemo-induced nausea and vomiting

Posted on: 07/10/2014 - 17:01

MADRID – The investigational neurokinin-1 receptor antagonist rolapitant met all of its endpoints in the prevention of chemotherapy-induced nausea and vomiting in a phase III trial. Among 532...

Field of Interest: Oncology

Type: News Item

New drug boosts survival in metastatic CRC

Posted on: 07/10/2014 - 14:50

MADRID – Treatment with a new nucleoside-analogue drug produced clinically meaningful improvements in survival and performance status in a phase III trial that enrolled 800 patients with metastatic...

Field of Interest: Oncology

Type: News Item

New drug boosts survival in metastatic CRC

Posted on: 07/10/2014 - 14:50

Field of Interest: Gastroentero...

Type: News Item

Biomarker predicts bone loss in premenopausal breast cancer patients

Posted on: 03/10/2014 - 19:17

CHICAGO – A premenopausal breast cancer patient’s follicle-stimulating hormone level upon completion of chemotherapy predicts her risk of bone loss during the ensuing 12 months, Dr. Laila S....

Field of Interest: Pulmonology

Type: News Item

Biomarker predicts bone loss in premenopausal breast cancer patients

Posted on: 03/10/2014 - 19:17

CHICAGO – A premenopausal breast cancer patient’s follicle-stimulating hormone level upon completion of chemotherapy predicts her risk of bone loss during the ensuing 12 months, Dr. Laila S....

Field of Interest: Oncology

Type: News Item

VIDEO: MEK/BRAF combo puts brakes on BRAF-mutated advanced melanoma progression

Posted on: 03/10/2014 - 14:10

MADRID – Combining the investigational MEK inhibitor cobimetinib with the BRAF inhibitor vemurafenib nearly halved the risk of progression in previously untreated patients with BRAF-mutated advanced...

Field of Interest: Oncology

Type: News Item

Gout may predispose people, particularly women, to diabetes

Posted on: 02/10/2014 - 23:30

Screen for diabetes and aggressively manage risk factors in patients with gout, especially women, investigators concluded from a retrospective, matched cohort study published Oct. 2 in Annals of the...

Field of Interest: Rheumatology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters